Literature DB >> 17142370

The presence of N-terminal secretion signal sequences leads to strong stimulation of the total expression levels of three tested medically important proteins during high-cell-density cultivations of Escherichia coli.

H Sletta1, A Tøndervik, S Hakvåg, T E Vee Aune, A Nedal, R Aune, G Evensen, S Valla, T E Ellingsen, T Brautaset.   

Abstract

Genetic optimizations to achieve high-level production of three different proteins of medical importance for humans, granulocyte-macrophage colony-stimulating factor (GM-CSF), interferon alpha 2b (IFN-alpha2b), and single-chain antibody variable fragment (scFv-phOx), were investigated during high-cell-density cultivations of Escherichia coli. All three proteins were poorly expressed when put under control of the strong Pm/xylS promoter/regulator system, but high volumetric yields of GM-CSF and scFv-phOx (up to 1.7 and 2.3 g/liter, respectively) were achieved when the respective genes were fused to a translocation signal sequence. The choice of signal sequence, pelB, ompA, or synthetic signal sequence CSP, displayed a high and specific impact on the total expression levels for these two proteins. Data obtained by quantitative PCR confirmed relatively high in vivo transcript levels without using a fused signal sequence, suggesting that the signal sequences mainly stimulate translation. IFN-alpha2b expression remained poor even when fused to a signal sequence, and an alternative IFN-alpha2b coding sequence that was optimized for effective expression in Escherichia coli was therefore synthesized. The total expression level of this optimized gene remained low, while high-level production (0.6 g/liter) was achieved when the gene was fused to a signal sequence. Together, our results demonstrate a critical role of signal sequences for achieving industrial level expression of three human proteins in E. coli under the conditions tested, and this effect has to our knowledge not previously been systematically investigated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17142370      PMCID: PMC1800768          DOI: 10.1128/AEM.01804-06

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  31 in total

1.  Parameters affecting gene expression from the Pm promoter in gram-negative bacteria.

Authors:  H C Winther-Larsen; K D Josefsen; T Brautaset; S Valla
Journal:  Metab Eng       Date:  2000-04       Impact factor: 9.783

Review 2.  Regulation of translation via mRNA structure in prokaryotes and eukaryotes.

Authors:  Marilyn Kozak
Journal:  Gene       Date:  2005-10-05       Impact factor: 3.688

3.  Overexpression and purification of recombinant human interferon alpha2b in Escherichia coli.

Authors:  Poonam Srivastava; Palash Bhattacharaya; Gaurav Pandey; K J Mukherjee
Journal:  Protein Expr Purif       Date:  2005-06       Impact factor: 1.650

Review 4.  Control of granulocytes and macrophages: molecular, cellular, and clinical aspects.

Authors:  D Metcalf
Journal:  Science       Date:  1991-10-25       Impact factor: 47.728

Review 5.  Advanced genetic strategies for recombinant protein expression in Escherichia coli.

Authors:  Hans Peter Sørensen; Kim Kusk Mortensen
Journal:  J Biotechnol       Date:  2005-01-26       Impact factor: 3.307

Review 6.  Strategies for achieving high-level expression of genes in Escherichia coli.

Authors:  S C Makrides
Journal:  Microbiol Rev       Date:  1996-09

7.  Overexpression of a synthetic gene encoding human alpha interferon in Escherichia coli.

Authors:  Fernanda O Neves; Paulo L Ho; Isaias Raw; Carlos A Pereira; Cristiani Moreira; Ana L T O Nascimento
Journal:  Protein Expr Purif       Date:  2004-06       Impact factor: 1.650

Review 8.  Secretory and extracellular production of recombinant proteins using Escherichia coli.

Authors:  J H Choi; S Y Lee
Journal:  Appl Microbiol Biotechnol       Date:  2004-02-14       Impact factor: 4.813

9.  Purification of recombinant human granulocyte-macrophage colony-stimulating factor from the inclusion bodies produced by transformed Escherichia coli cells.

Authors:  M Belew; Y Zhou; S Wang; L E Nyström; J C Janson
Journal:  J Chromatogr A       Date:  1994-09-09       Impact factor: 4.759

10.  Translational features of human alpha 2b interferon production in Escherichia coli.

Authors:  C A Valente; D M F Prazeres; J M S Cabral; G A Monteiro
Journal:  Appl Environ Microbiol       Date:  2004-08       Impact factor: 4.792

View more
  37 in total

1.  Design and optimization of short DNA sequences that can be used as 5' fusion partners for high-level expression of heterologous genes in Escherichia coli.

Authors:  Veronika Kucharova; Jørgen Skancke; Trygve Brautaset; Svein Valla
Journal:  Appl Environ Microbiol       Date:  2013-08-23       Impact factor: 4.792

Review 2.  Stepwise optimization of recombinant protein production in Escherichia coli utilizing computational and experimental approaches.

Authors:  Kulandai Arockia Rajesh Packiam; Ramakrishnan Nagasundara Ramanan; Chien Wei Ooi; Lakshminarasimhan Krishnaswamy; Beng Ti Tey
Journal:  Appl Microbiol Biotechnol       Date:  2020-02-19       Impact factor: 4.813

3.  Homologous Quorum Sensing Regulatory Circuit: A Dual-Input Genetic Controller for Modulating Quorum Sensing-Mediated Protein Expression in E. coli.

Authors:  Pricila Hauk; Kristina Stephens; Chelsea Virgile; Eric VanArsdale; Alex Eli Pottash; John S Schardt; Steven M Jay; Herman O Sintim; William E Bentley
Journal:  ACS Synth Biol       Date:  2020-09-15       Impact factor: 5.110

4.  A comprehensive in silico characterization of bacterial signal peptides for the excretory production of Anabaena variabilis phenylalanine ammonia lyase in Escherichia coli.

Authors:  Hajar Owji; Shiva Hemmati
Journal:  3 Biotech       Date:  2018-11-16       Impact factor: 2.406

5.  Combinatorial mutagenesis and selection of improved signal sequences and their application for high-level production of translocated heterologous proteins in Escherichia coli.

Authors:  Tonje Marita Bjerkan Heggeset; Veronika Kucharova; Ingemar Naerdal; Svein Valla; Håvard Sletta; Trond Erling Ellingsen; Trygve Brautaset
Journal:  Appl Environ Microbiol       Date:  2012-11-09       Impact factor: 4.792

6.  The human alpha(2)-plasmin inhibitor: functional characterization of the unique plasmin(ogen)-binding region.

Authors:  Simon S Gerber; Sofia Lejon; Michael Locher; Johann Schaller
Journal:  Cell Mol Life Sci       Date:  2010-01-29       Impact factor: 9.261

7.  Analysis of type II secretion of recombinant pneumococcal PspA and PspC in a Salmonella enterica serovar Typhimurium vaccine with regulated delayed antigen synthesis.

Authors:  Wei Xin; Soo-Young Wanda; Yuhua Li; Shifeng Wang; Hua Mo; Roy Curtiss
Journal:  Infect Immun       Date:  2008-05-05       Impact factor: 3.441

8.  Random mutagenesis of the PM promoter as a powerful strategy for improvement of recombinant-gene expression.

Authors:  Ingrid Bakke; Laila Berg; Trond Erik Vee Aune; Trygve Brautaset; Håvard Sletta; Anne Tøndervik; Svein Valla
Journal:  Appl Environ Microbiol       Date:  2009-02-05       Impact factor: 4.792

9.  Co-expression of two fibrolytic enzyme genes in CHO cells and transgenic mice.

Authors:  Miaorong Huang; Zicong Li; Xiaoling Huang; Wenchao Gao; Cailin Zhu; Hui Xu; Yujuan Yuan; Liang Shuai; Ruiai Chen
Journal:  Transgenic Res       Date:  2013-01-22       Impact factor: 2.788

10.  Strategies for successful recombinant expression of disulfide bond-dependent proteins in Escherichia coli.

Authors:  Ario de Marco
Journal:  Microb Cell Fact       Date:  2009-05-14       Impact factor: 5.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.